Topic: HIKMA PHARMACEUTICAL
9 results were found.
California AG announces $150 million multistate agreement with Hikma Pharmaceuticals for its role in opioid epidemic - February 6, 2024
Hikma Pharmaceuticals acquires Custopharm for $425m - April 25, 2022
Hikma Pharmaceutical acquires Teligent for $45.8 million - January 17, 2022
Hikma Pharmaceuticals appoints Sigurdur Olafsson as CEO - February 21, 2018
Hikma Pharmaceuticals names John J. Castellani as director - February 23, 2016
Jochen Gann joins Hikma Pharmaceuticals board - December 28, 2015
Hikma Pharmaceuticals names Pamela Kirby director - November 10, 2014
Hikma Pharmaceuticals changes organisational structure - March 14, 2014
Hikma Pharmaceuticals changes its board - February 12, 2014